About Qeen Biotechnologies
Transforming therapeutics with advanced bacteriophage solutions.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Gatineau, Quebec
- Founded
- 2022
- Company type
- Privately Held
Qeen Biotechnologies is a global Center of Excellence for the biomanufacturing of nontraditional therapeutics. We provide services for the development and production of GMP and non-GMP bacteriophages and related delivery systems for the life sciences, pharmaceutical, agricultural, and veterinary industries.
Qeen Biotechnologies has established a world-class 4,377 sqft biologics biomanufacturing facility, equipped with ISO-6, ISO-7, and ISO-8 GMP compliant cleanrooms, unidirectional traffic flow, and stringent environmental, safety, and production controls. Our facility and expertise aim to address the entire phage care continuum for AMR infections, from screening to manufacturing and therapy.
Our comprehensive and patient-centric approach to phage care allows clinicians to offer precise phage treatments more quickly and at a lower cost, ultimately helping patients live longer, healthier lives. Qeen Biotechnologies is the only Canadian manufacturing facility producing GMP and non-GMP bacteriophages at large scales, effectively tackling the high costs of biologics production and the increasing number of AMR cases.
Company locations
1-669 Rue Auguste-Mondoux, Gatineau, Quebec J9J3K3, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
On LinkedIn
- Followers
- 2,808
- People linked to this company
- 10
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.